We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
The ASX200 closed down 0.75% at 8,193 points. Analyst consensus is now that Trump will introduce...
Read ArticleIDT Australia (ASX:IDT) has confirmed its proposed takeover offer from a company called Myndbio for...
Read ArticleASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results...
Read ArticleHealthcare stocks are doing relatively well globally in 2024 The sector could see more recovery as...
Read ArticleASX health stocks down in August and trail the broader market in 2024 CSL up 6,000pc since listing;...
Read ArticleNeuren shows promise in Angelman drug but shares down 7pc Avita aims for profitability by Q3 FY25 I...
Read ArticleS&P/ASX 200 Health Care index up 5pc in July, 9.5pc YTD Health sector gains momentum with expec...
Read ArticleThe EMA has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen There is one ASX-l...
Read ArticleHITIQ has secured a pivotal US patent for its Nexus technology BlinkLab has joined forces with Ment...
Read ArticlePharmaceutical manufacturer and medicinal cannabis group IDT Australia (ASX: IDT) has sweetened the...
Read ArticleThe cannabis industry is poised for growth, driven by evolving legalisation globally Investment opp...
Read ArticleThe ASX Health Care index saw a 4% increase in June Growth was driven by CSL and Cochlear Best biot...
Read ArticleFDA panel rejects MDMA for PTSD treatment, citing safety and data concerns Advocates argue MDMA’s b...
Read ArticleAussie shares rally Rate sensitive stocks gain, led by Tech FTL soars on Newfoundland deal Aussi...
Read ArticleS&P/ASX 200 Health Care closed flat in May 2024 brings challenges, but hopes are high for biot...
Read ArticleResearch shows Alzheimer’s is entirely preventable A poor diet and bad gut bacteria can increase th...
Read ArticlePharmaceutical manufacturing company IDT Australia (ASX: IDT) has been awarded a grant by the Victor...
Read ArticleASX Health sector was in correction territory in April Why is the health sector different from othe...
Read ArticleThere’s been a breakthrough in acne treatment Scientists have found a way to use skin bacteria to c...
Read ArticleWhere are we in terms of US legalisation of cannabis? What about the current legal landscape for ca...
Read ArticleAustralian shares declined sharply following stronger-than-expected US retail sales data, dampening...
Read ArticlePaul McDonald – CEO – IDT Australia (ASX:IDT) is an expert partner in the production and manufactu...
Read ArticleStudy shows cannabis can kill melanoma cells Germany has voted to legalise cannabis possession The...
Read ArticleASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essenti...
Read ArticleBy Tim Boreham, Editor, The New Criterion Profit season brings out the best and worst in small caps...
Read ArticleViking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on p...
Read ArticleMike Tyson has spoken out against the jailing of cannabis users Iron Mike owns his own cannabis bra...
Read ArticleXi and Biden set to agree on restricting fentanyl Fentanyl is a synthetic opioid responsible for t...
Read ArticleJamaican nettletree is said to contain traces of cannabidiol (CBD) Victoria set to launch a medical...
Read ArticleStockhead’s In-Case-You-Missed-It highlights today’s most interesting small cap stories that might h...
Read ArticleIDT provides strong quarterly update Paradigm tumbles 30pc after emerging from trading halt IDT’...
Read ArticleCannabis stocks could rise after the removal of US House Speaker Montu says TGA has to allow the te...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleBig win for cannabis as SAFER Banking Act set to be passed in the US Australia’s cannabis industry...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleCannabis stocks jumped after marijuana rescheduling recommendation in the US Study in Australia sho...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleThe US is about to follow Australia’s footsteps and approve psychedelics The FDA is currently await...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleTim Boreham outlines the rise and fall of IDT Australia, and its potential revival in the cannabis a...
Read ArticleMastercard says no to weed transactions New York is where weed is happening Jeremy Buckingham pulls...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleSocial media platforms are rushing to update their advertising policies on cannabis Meta was the mo...
Read ArticleSince TGA’s down-scheduling of CBD last year, no products have been sold in Australia But the race...
Read ArticleThe ASX is expected to open lower today, following a downward trend on global markets overnight....
Read ArticleThe weed industry has slumped as it faces several headwinds But new data suggests the industry will...
Read ArticleS&P/ASX 200 closes up 1% – its best performance in about a week All sectors bar IT and Utiliti...
Read ArticleStockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) pe...
Read ArticleThe world is experiencing a ‘shroom boom’ Psychedelics are expected to follow in cannabis’ explosiv...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticleThe ASX 200 rose 0.30%, as the day turned out flattish to half decent, rather than deadset flattene...
Read ArticleResearch in Australia shows marijuana helps with chronic pain and insomnia The rules around getting...
Read ArticleStudies confirm that cannabis relieves pain in cancer patients In addition, cannabis also improves...
Read ArticleThe S&P ASX 200 finished up 1.85% in April while mid and small caps outperformed their blue-chi...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleThe 420 Day is unofficially the World Marijuana Day, and we look at the possible origins of this da...
Read ArticleThe number of Aussies using legal instead of illicit medical cannabis is rising The main reason for...
Read ArticleNoxopharm has developed a new product candidate based on mRNA technology IDT nabs TGA licence exten...
Read ArticleIDT Australia (ASX:IDT) has announced that the TGA has expanded the licensing conditions cov...
Read ArticleChemist Warehouse joins WNX JV to develop new cannabis products Neurotech launches new clinical pro...
Read ArticleThe ASX slid to close flat today, after realising we were in danger of making some money Materials...
Read ArticleTwitter to allow cannabis companies to advertise in US states where it’s legal Elixnol comes out on...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleUS States who allow recreational cannabis see less codeine demand WA GP wants Snoop Dogg to drop in...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticlePenington Institute says pot-related law enforcement costs us $1.7 billion a year Local cannabis...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleTwo more US states join the 19 that already allow legal recreational cannabis use ECS Botanics’ Vic...
Read ArticleGermany looks to legalise recreational cannabis and US and Canadian companies are paying attention ...
Read ArticleAmid a worldwide surge of interest in using psychedelic substances to treat stubborn mental health c...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleAustralian pharmaceutical manufacturing company IDT Australia (ASX:IDT) has announced the ap...
Read ArticleBlood clot programs have taken the spotlight recently as new discoveries made Two ASX health stocks...
Read ArticleCambridge says cannabis smokers are not actually lazy, that’s a myth USyd wants to test home-grown...
Read ArticlePatrys gets research grant to progress lead drug Next Science gets Canada license Bad news for ID...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleResearchers say data shows transition from illicit to legal use of cannabis Medicinal users are at...
Read ArticleIce-T is opening a cannabis dispensary in New Jersey this year Snoop Dogg’s venture capital firm le...
Read ArticleMysterious pink glow over Mildura Thailand businesses go nuts for CBD desserts and bubble tea ECS n...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleECS is selling its medicinal cannabis farm in Tasmania Crypto ATMs are now a thing in weed dispensa...
Read ArticleASX biotech shares were hammered in FY22 with the sector facing heavy losses, in line with the wide...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleRetail and independent cannabis lounges could be opening soon in Vegas Cann Group gets good manufa...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleA Thai university says adding cannabis to chicken feed has positive results on meat and egg quality...
Read ArticleEmerging Companies (XEC) index jumps more than 2% before trimming gains Benchmark ASX200 down 0.1...
Read ArticleBoston Beer Co launches cannabis iced tea in Canada University of Sydney says using CBD and driving...
Read ArticleActor Woody Harrelson has opened a cannabis store in West Hollywood Releaf has plans for a weed wel...
Read ArticleActor and cannabis farmer Jim Belushi is headlining the Grow Up Conference and Expo next month Fran...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleUS Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleThe healthcare sector is Australia’s biggest employer, employing 1 in 7 Aussies or roughly two milli...
Read ArticleThe ACIC says weed consumption increased in cities and regions ROO receives USA design patent appro...
Read ArticleMake it three on the trot for the ASX microcap Emerging Companies index, which rose by more than 1%...
Read ArticleIDT Australia (IDT) has been unsuccessful in its application for a grant under the Federal Governme...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleHemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The leg...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleThe S&P/ASX200 climbed into the close on Tuesday. Most of the 35 or so point gain (0.5%) comes...
Read ArticleAs inflation sticks around and rate hikes come into play then volatility will pick up, the general c...
Read ArticleIn December France banned the sale of hemp flower and leaf loaded with CBD, but the Conseil d’Etat...
Read ArticleThe ASX closed the second last trading day of the year – and the last full day of the year – slightl...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleThe life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, th...
Read ArticleThe Australian medicinal cannabis market has seen strong growth in 2021, with revenue from product s...
Read ArticleEach week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength In...
Read ArticleThis week has been a good time to be a company helping in the front line fight against COVID-19 but...
Read ArticleWhile US markets rose after the Fed outlined plans to gradually withdraw stimulus, our markets did n...
Read ArticleIDT Australia’s (IDT) submission for the Australian Government’s Approach To Market for an onshore...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price is crashing down to Earth on Thursday morning. At...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleJ-Pow and the gang are back on deck with a bang later tonight, and ASX investors appeared to buckle...
Read ArticleResources stocks Quantum Graphite (ASX:QGL) and Altura Mining (ASX:AJM) were reinstated after being...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price is on ice today after the company requested a trad...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price has been up and down today, currently down 2.46% t...
Read ArticleThe Starpharma Holdings Limited (ASX: SPL) share price is racing ahead this morning after confirmin...
Read ArticleHighlights The new COVID-19 variant Omicron is gradually approaching many counties around the w...
Read ArticleThe ASX returned to positive territory today as investors began to shrug off fears of the omicron va...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price is entering the stratosphere today. This comes aft...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleUber is expanding its horizons, with plans to allow users to order cannabis on its Uber Eats app. Ne...
Read ArticleInstead of a chocolate advent calendar this year, Californians can get their hands on a cannabis cal...
Read ArticleActor Jim Belushi has partnered with – you guessed it – Dan Aykroyd on a tour through Oklahoma’s can...
Read ArticleLast week California Governor Gavin Newsom signed Assembly Bill (AB-45), formally permitting the sal...
Read ArticleIDT Australia (IDT) partners with the Monash University to produce a drug product for an mRNA COVID...
Read ArticleRetail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired f...
Read ArticleOnce again the energy sector determined the direction of the market but unlike yesterday where it ga...
Read ArticleThe Boston Beer Company (NYSE:SAM) is set to launch a new range of non-alcoholic cannabis-infused dr...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price has slipped into the red during early trade on Tue...
Read ArticleAugust was another month of lockdown for much of Australia’s East Coast but lockdowns and even a 2%...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleHot Money Monday is typically the domain of ASX small caps, but this week saw plenty of larger compa...
Read ArticleThe ASX 200 closed at 7,488 points which was 0.04% down from yesterday but up 0.37% from last Friday...
Read ArticleVirginia is the latest US state to legalise marijuana and they’re celebrating with the first annual...
Read ArticleHighlights ASX-listed healthcare companies rarely fail to bring joy to the market participants,...
Read ArticleThe ASX 200 health stocks index (XHJ) rose by 0.60% this morning, compared to the broader index whic...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price has soared into the green during early trade on Mo...
Read ArticleIDT Australia (ASX:IDT) jumped more than 20% after announcing that it has formalised activities with...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIkwezi Mining (ASX:IKW) topped the latest Running Hot list with a 14-day RSI of 82, after two straig...
Read ArticleAnother red day for the ASX to close out the week. The ASX 200 closed 0.05% down from yesterday at 7...
Read ArticleWhile today was a better day for the ASX than the past two days, the bourse still finished slightly...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price is shooting 25% higher after The Sydney Morning He...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleMassachusetts based cannabis operator MariMed has just announced a joint collaboration with the lege...
Read ArticleTrading Places is Stockhead’s recap of the buys and sells of ASX small cap shares by fund managers a...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleThe Community College of Denver (CCD) has just launched a cannabis business program in Colorado. The...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleThis week Technicorum Holdings announced an upcoming token sale and launch of The CanCoin – a cannab...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading d...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleIf discussions continue, IDT is poised to provide its current good manufacturing process (cGMP) to h...
Read ArticleThe IDT Australia Limited (ASX: IDT) share price has been a very strong performer on Tuesday. In la...
Read ArticleThe US cannabis sector received a big lift after Amazon announced that job applicants at its offices...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleThere was plenty of action in the US regulatory front within the cannabis sector this week. A couple...
Read ArticleIt was a good day for some of ASX-listed cancer therapy stocks yesterday, with three companies relea...
Read ArticleIn 2021, which of Europe and North America is the place to be for ASX cannabis stocks? The case fo...
Read ArticleA cannabis-based drug has been listed on Australia’s Pharmaceutical Benefits Scheme for the first ti...
Read ArticleASX pot stocks have run hot in recent months but eight in particular have been particularly rewardin...
Read ArticleSummary Australian players MGC Pharmaceuticals and ArchTIS limited were under the spotlight foll...
Read ArticleApril 20 has come and gone, but ASX cannabis companies aren’t getting that high — they’re actually l...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleSummary Emyria has received firm commitments in a well-supported placement to raise AU$5 million...
Read ArticleSource: Have a nice day Photo, Shutterstock Summary Telix Pharmaceuticals has announced the lau...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleShares in CSL (ASX:CSL) and IDT Australia (ASX:IDT) both fell early after the latest setback to Aust...
Read ArticleThe number of medical cannabis prescriptions issued under Australia’s special access scheme just kee...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read ArticleMarch got off to a rough start, with ASX small caps suffering their worst week since October and the...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read ArticleAustralia’s medical marijuana industry is showing strong growth, according to an industry-leading bi...
Read ArticleStockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical ga...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read ArticleThe North American cannabis market received another shot in the arm this week, after legislation per...
Read ArticleSource: whiteMocca, Shutterstock The S&P/ASX 200 gained substantially and closed 0.66% higher a...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read ArticleThe IDT Australia Limited (ASX: IDT) share price was on fire again on Monday. The pharmaceutical ma...
Read ArticleMedtech company Oneview Health (ASX:ONE) led 25 stocks that chalked up a 14-day RSI above 70 this we...
Read ArticleSmall caps have closed lower today, but they finished the week in the green for a second week in a r...
Read ArticleVictorian pharmaceuticals manufacturer IDT Australia (ASX: IDT) has announced it is looking into the...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest movers – the winners and losers alike....
Read ArticleIDT Australia Limited (ASX: ITD) shares are soaring today after the company announced it has been a...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticlePot legalisation is creeping across the US state by state, and a major market could be about to join...
Read ArticleSource: Shutterstock Summary IDT has posted a net profit of $1.12 million in 1H FY21. During t...
Read ArticleSummary In 2020, the stock market stayed highly volatile due to the negative impact of the coron...
Read ArticleASX cannabis stocks are continuing their victory lap following yesterday’s decision by the TGA to re...
Read ArticleASX cannabis shares faded from the spotlight in 2020 as the coronavirus pandemic took over. But the...
Read ArticleCannabis shares were considered a fad for a while. Now, they’ve proved they’re here to stay. As the...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small ca...
Read ArticleAustralian cannabis developer Cann Group (ASX: CAN) has signed two agreements for the supply of medi...
Read ArticleWant to know which stocks the fund managers have been putting their money in (and out) of? We’ve kee...
Read ArticleTom Bleakley, BW Equities BUY RECOMMENDATIONS IDT Australia (IDT) Chart: Share price over the year I...
Read ArticleBefore 1942, Australia hadn’t fully come to terms with what a world war would require it to do. By t...
Read ArticleAs with the early medical cannabis plays, a cluster of ASX-listed stocks has wasted little time atta...
Read ArticleReporting season wrapped up last week with the S&P/ASX 200 Index (INDEXASX: XJO) falling more t...
Read ArticleThe Cann Group Ltd (ASX: CAN) share price has plunged 5.15% in early trade after the cannabis culti...
Read ArticleFollowing a 30 per cent gain in 2019, the S&P/ASX Emerging Companies index – which measures over...
Read ArticleASX cannabis shares endured a tough 2019, as investors cooled on the latest investing trend. Howeve...
Read ArticleThe All Ordinaries index has started 2020 in an exceptionally positive fashion. The year may be jus...
Read ArticleShares in Cann Group Ltd (ASX: CAN) rose to fresh highs for the year yesterday. The Cann Group shar...
Read ArticleOnly one prescription for medical marijuana has been issued by a doctor in the Northern Territory, a...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleThe Cann Group Ltd (ASX: CAN) share price was on form again on Monday and recorded another strong g...
Read ArticleAs the world learns tasty cannabis edibles might not be the safest of munchies, Australian investors...
Read ArticleCann Group (CAN) and IDT Australia (IDT) have announced that GMP extraction activities are underway...
Read ArticleCann Group (ASX: CAN) and IDT Australia (ASX: IDT) are closer to producing their first medicinal can...
Read ArticleCann Group’s (ASX: CAN) manufacturer has started making cannabis resin from the company’s plants, an...
Read Article07 Jan 2020 - The Cann Group (ASX:CAN) and IDT Australia (ASX:IDT) have jointly announced that GMP e...
Read ArticleThe Cann Group Ltd (ASX: CAN) share price has returned from its trading halt and rocketed higher. I...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleFew people are at their desks in the week between Christmas and new year, which means it’s a prime d...
Read ArticleThe Cann Group Ltd (ASX: CAN) share price was the best performer on the All Ordinaries index on Mon...
Read ArticleThis year was a difficult one for ASX cannabis shares as well as cannabis stocks globally with shar...
Read ArticleInvion (ASX:IVX) may have a new Chinese partner to help get its cosmetics business off the ground. T...
Read ArticleCannabis industry is booming at a rapid pace, with several governments creating opportunities for in...
Read ArticleThe AusCann Group Holdings Ltd (ASX: AC8) share price certainly was out of form on Thursday. The me...
Read ArticleIn afternoon trade the S&P/ASX 200 index is on course to finish the day lower. At the time of w...
Read ArticleThe new COO has more than 30 years’ experience in the pharmaceutical industry in Australia and the U...
Read ArticleCann Global (ASX:CGB) has become the second small cap to enter the African cannabis market. It is a...
Read ArticleCann Group (ASX: CAN) has confirmed the first commercial medicinal cannabis product to be made at Ca...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleIn morning trade the Cann Group Ltd (ASX: CAN) share price is rocketing higher. At the time of writ...
Read ArticleIn the global medical cannabis market scenario, Australian cannabis market is the fastest one growin...
Read ArticleLately, cannabis stocks in the US have come under pressure, following the rising death toll from vap...
Read ArticleCannabis Industry The Australian cannabis industry is the newest and the most dynamic sector after t...
Read ArticleThe Cann Group Ltd (ASX: CAN) share price is having a rare positive day of trade. In morning trade...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleCannabis industry in Australia is growing at a fast pace, and government authorities across the coun...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleShares in biotech Orthocell (ASX:OCC) are on the move again today after the company reported further...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleCannabis: An Overview The cannabis industry is booming at a rapid pace with governments across the g...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleThe increasing use of medical cannabis products has prompted many countries to soften the regulation...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleThe progress of the Australian medical cannabis industry since its legalisation indicates that the c...
Read ArticleThe Cann Group Ltd (ASX: CAN) share price could trade heavily this morning after the medicinal can...
Read ArticleCannabis can be understood as a nature-oriented medicine from the cannabis plants, used for medical...
Read ArticleAustralia’s pharmaceutical industry is innovative and immensely supports economic prosperity of the...
Read ArticleOne of Australia’s leading cannabis developers, Cann Group (ASX: CAN) has been approved to manufactu...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleWth the legalisation of medical cannabis in many countries like Canada, the global medical cannabis...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read ArticleMedical cannabis uses the marijuana plant or chemicals extracted from the plant for the treatment of...
Read ArticleInternational research suggests shares in companies that buy in their own equities are more likely t...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
